Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample Mendelian randomization study

  • N. Ahmad Aziz
  • Patrick Weydt
Letter to the Editors


Compliance with ethical standards

Conflicts of interest

Dr Aziz and Dr Weydt report no conflicts of interest.


  1. 1.
    GeM-HD Consortium (2015) Identification of genetic factors that modify clinical onset of Huntington’s disease. Cell 162(3):516–526CrossRefGoogle Scholar
  2. 2.
    Kota LN, Bharath S, Purushottam M et al (2015) Reduced telomere length in neurodegenerative disorders may suggest shared biology. J Neuropsychiatry Clin Neurosci 27(2):e92–e96CrossRefPubMedGoogle Scholar
  3. 3.
    Zhan Y, Song C, Karlsson R et al (2015) Telomere length shortening and Alzheimer disease—a Mendelian randomization study. JAMA Neurol 72(10):1202–1203CrossRefPubMedGoogle Scholar
  4. 4.
    Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89–R98CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Codd V, Nelson CP, Albrecht E et al (2013) Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 45(4):422–427CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hemani G, Zheng J, Wade KH et al (2016) MR-base: a platform for systematic causal inference across the phenome using billions of genetic associations. bioRxiv. Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.German Centre for Neurodegenerative Diseases (DZNE)BonnGermany
  2. 2.Department of Neurodegenerative Diseases and GerontopsychiatryUniversity of Bonn Medical CentreBonnGermany

Personalised recommendations